Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

2.8K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.8K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

174
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCL21 and CLDN11 Are Key Driving Factors of Lymph Node Metastasis in Gastric Cancer.

Cancer control : journal of the Moffitt Cancer Center·2024
Same author

SOX12 Promotes Thyroid Cancer Cell Proliferation and Invasion by Regulating the Expression of POU2F1 and POU3F1.

Yonsei medical journal·2022
Same author

Calculation of state-to-state differential and integral cross sections for atom-diatom reactions with transition-state wave packets.

The Journal of chemical physics·2014
Same author

[Natural attenuation of tetracycline in the water of Taihu Lake under different environmental conditions].

Huan jing ke xue= Huanjing kexue·2014
Same author

The role of AhR in autoimmune regulation and its potential as a therapeutic target against CD4 T cell mediated inflammatory disorder.

International journal of molecular sciences·2014
Same author

Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population.

Lipids in health and disease·2014

Related Experiment Video

Updated: Jul 4, 2025

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
04:42

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery

Published on: February 17, 2023

1.4K

Optimizing Levothyroxine Replacement: A Precision Dosage Model for Post-Thyroidectomy Patients.

Guanghua Yang1, Jiaxi Pu1, Sibo Zhu2

  • 1Department of General Surgery, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, People's Republic of China.

International Journal of General Medicine
|February 7, 2024
PubMed
Summary

Optimizing levothyroxine (LT4) dosage after thyroidectomy is complex. This study identified key patient factors, including benign/malignant status and specific blood markers, to predict optimal LT4 dosage for improved treatment outcomes.

Keywords:
dosagelevothyroxinemodelpredictionthyroid

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.7K
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

265

Related Experiment Videos

Last Updated: Jul 4, 2025

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
04:42

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery

Published on: February 17, 2023

1.4K
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.7K
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

265

Area of Science:

  • Endocrinology
  • Oncology
  • Clinical Chemistry

Background:

  • Thyroidectomy for thyroid tumors frequently leads to hypothyroidism, necessitating levothyroxine (LT4) hormone replacement.
  • Achieving optimal LT4 dosage is critical for maintaining normal hormone levels and suppressing TSH in cancer patients, yet it remains a clinical challenge.
  • Suboptimal LT4 dosing can result in uncertain treatment outcomes and adverse side effects.

Purpose of the Study:

  • To identify key clinical and laboratory variables that predict optimal levothyroxine (LT4) dosage in patients following total thyroidectomy.
  • To develop a predictive model for LT4 dosage to enhance treatment efficacy and patient management post-thyroidectomy.

Main Methods:

  • Analysis of clinical and laboratory data from 510 total thyroidectomy patients.
  • Application of data preprocessing, Principal Component Analysis, correlation, and regression analyses on 274 samples with 98 variables using R.
  • Identification of significant factors influencing satisfactory LT4 tablet dosage.

Main Results:

  • Eight variables significantly impacted optimal LT4 dosage: benign/malignant status, electrophoretic albumin ratio (BQB), total protein (TP), fibrin degradation products (FDP), thyroid-stimulating hormone receptor antibody (TRAB_1), prothrombin time (PT), monocyte count (MONO#), and hepatitis C antibody (HCV0C).
  • A predictive linear model was established based on these significant variables.

Conclusions:

  • Patient characteristics such as benign/malignant status, TRAB_1, and BQB ratio serve as valuable indicators for guiding postoperative LT4 dosage.
  • The developed linear model offers a tool for predicting LT4 dosage, potentially improving treatment effectiveness and optimizing resource utilization in thyroidectomy patients.